← Human Trials & Peer-Reviewed Studies
[Decapeptyl (triptorelin) in the treatment of endometriosis genitalis externa]
Plain-language guide to PMID 11526759 (2001): randomized controlled trial study of Triptorelin in 69 patients, endometriosis.
Key Facts
- PMID
- 11526759
- Journal
- Ginekologia polska
- Year
- 2001
- Study type
- Randomized Controlled Trial
- Authors
- Palatyński A et al. (2 authors)
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Triptorelin in the context of endometriosis, published as a randomized controlled trial.
The study involved 69 patients in whom endometriosis was diagnosed.
The patients were divided into three groups randomly.
Who Took Part
The abstract describes 69 patients taking part.
PubMed indexes the participants as adults and middle-aged adults, women only.
How the Study Was Run
The researchers set it up as a randomized study.
Random assignment meant chance, not the researchers, decided who got Triptorelin and who got the comparison, which limits bias.
What Was Measured
Topics PubMed links to this paper include Antineoplastic Agents, Hormonal, Endometriosis, Pelvic Inflammatory Disease and Triptorelin Pamoate.
What This Means in Plain Language
The paper is a randomized study of Triptorelin in 69 patients in people with endometriosis.
The publication is from 2001 (Ginekologia polska), a journal based in Poland.
More context: the Triptorelin compound page, Endometriosis research.
Our Notes on the Compound
Triptorelin: A 10-amino-acid GnRH analog (Trelstar, Decapeptyl, Triptodur) used in prostate cancer, early puberty and fertility protocols.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.